Zimmer Biomet (ZBH) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Zimmer Biomet · Health Care · ref. ETF XLV · 50 calls · price $92.08
What the company does: Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide.
📈 Zimmer Biomet (ZBH) stock price
$92.08-6.4% over range
Oct 14, 25low $79.58 · high $103.98Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
33% recommend buying · 12 analysts
📊 JPI status : Zimmer Biomet has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 ZBH price target & analyst consensus — price $92.08
The price target · all analysts combined (12 targets)
Highest target · 3 firms of 12$110+19.5%
Median target · of 12 targets$100+8.6%
Lowest target · 1 firm of 12$90-2.3%
Current price$92.08
Where these 12 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
1192%
$93 ↔ $110
Below
18%
$90
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Bernstein — 69% of its targets hit on this sector (70 calls tested). It aims for $93 (+1.0 %), call made on August 7, 2026, maturing on August 7, 2027 (68 d ago).
The 5 reliable analysts
$100+8.6 %
The 7 other firms
$95+3.2 %
How to read it: the 5 reliable firms are not filtered by optimism — 5 aim above the price, 0 below, hence their $100 median. “The 7 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 12 ratings (last 6 months)
Strong Buy00%
Buy433%
Hold867%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 ZBH price target all
All 50 calls, one by one, with our verdict on each firm.
→ See all 50 targets, analyst by analyst💡 The best analysts on ZBH most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in ZBH? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Zimmer Biomet? The JPI assistant answers using our backtest data.
💰 Zimmer Biomet dividend: yield, history & growth › open the full page
1.14%annual yield
That's ~$0.96 per share per year.
📈 Zimmer Biomet fundamentals: valuation, margins & growth › open the full page
P/E 22.3Net margin 9.5 %Revenue growth +4.8 %Cheap for the growth
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 3 %
2023
Rev +7%Profit +343%
2024
Rev +4%Profit −12%
2025
Rev +7%Profit −22%
🔎 Detailed analyses
✅ Historical analyst reliability on ZBH
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Truist Securities ↗ | 100% | +9.6% | 2 |
| Goldman Sachs ↗ | 100% | +3.9% | 3 |
| BMO Capital ↗ | 100% | +3.4% | 2 |
| SunTrust Robinson Humphrey | 75% | +22.4% | 4 |
| Citigroup ↗ | 71% | +10.3% | 14 |
| Piper Sandler ↗ | 71% | +7.9% | 7 |
| Leerink Swann | 67% | -1.8% | 3 |
| Morgan Stanley ↗ | 64% | +6.7% | 14 |
| SVB Leerink | 58% | +3.6% | 12 |
| UBS ↗ | 57% | +9.7% | 7 |
See the other 17 firms
| Evercore ISI Group ↗ | 0% | -12.8% | 3 |
| JP Morgan ↗ | 0% | -11.4% | 3 |
| RBC Capital ↗ | 0% | -10.2% | 11 |
| Argus Research ↗ | 0% | -6.7% | 4 |
| Oppenheimer ↗ | 14% | -4.4% | 7 |
| Stifel ↗ | 31% | +6.0% | 16 |
| Baird ↗ | 33% | -6.0% | 12 |
| Raymond James ↗ | 33% | +0.2% | 21 |
| BTIG ↗ | 33% | +3.0% | 6 |
| JMP Securities | 36% | -4.6% | 14 |
| Wells Fargo ↗ | 38% | -1.2% | 8 |
| Credit Suisse | 40% | -10.7% | 5 |
| Jefferies ↗ | 50% | -0.6% | 4 |
| Canaccord Genuity ↗ | 50% | +0.2% | 4 |
| Loop Capital ↗ | 50% | +4.8% | 2 |
| Needham ↗ | 53% | +0.5% | 17 |
| Barclays ↗ | 57% | +0.3% | 14 |
📊 What $1,000 invested in Zimmer Biomet would be worth › open the full page
In short — $1,000 invested in Zimmer Biomet 10 years ago would be worth $864 today, i.e. -1%/yr on average. Best year: 2019 (+44%), worst: 2021 (-18%). Price performance, excluding dividends.
If I'd invested $1,000 in Zimmer Biomet
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $815 | -18% |
| 3 years ago | $675 | -32% |
| 5 years ago | $575 | -42% |
Return by year (Zimmer Biomet)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -4% | $957 (-4%) |
| 2025 | -15% | $815 (-18%) |
| 2024 | -13% | $707 (-29%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Zimmer Biomet
Loading news…
📋 All analyst calls on ZBH
Filtered on — · ✕ show all
■ Equal-Weight neutral · not a buy · 🎯$100
Price at call : $88.49 — gap to target +13%
Today : $92.08 — gap to target +9%
🎯 on ZBH : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Oct 7, 27
matures : Oct 7, 27
Canaccord Genuity ↗
Aug 10, 26
■ Hold neutral · not a buy · 🎯$100
Price at call : $97.78 — gap to target +2%
Today : $92.08 — gap to target +9%
🎯 on ZBH : no call matured yet · 📊 on Health : 52.6% · +5.0% (154 calls)
in progress (365j)
matures : Aug 10, 27
matures : Aug 10, 27
Truist Securities ↗
Aug 7, 26
■ Hold neutral · not a buy · 🎯$106
Price at call : $96.55 — gap to target +10%
Today : $92.08 — gap to target +15%
🎯 on ZBH : no call matured yet · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
RBC Capital ↗
Aug 6, 26
▲ Outperform · 🎯$110
Price at call : $96.55 — upside +14%
Today : $92.08 — upside +19%
🎯 on ZBH : 0% (1 call matured) · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Aug 6, 27
matures : Aug 6, 27
■ Market Perform neutral · not a buy · 🎯$93
Price at call : $96.55 — gap to target -4%
Today : $92.08 — gap to target +1%
🎯 on ZBH : no call matured yet · 📊 on Health : 55.7% · +5.7% (70 calls)
in progress (365j)
matures : Aug 6, 27
matures : Aug 6, 27
▲ Buy · 🎯$110
Price at call : $96.55 — upside +14%
Today : $92.08 — upside +19%
🎯 on ZBH : 0% (2 calls matureds) · 📊 on Health : 50.7% · +7.8% (304 calls)
in progress (365j)
matures : Aug 6, 27
matures : Aug 6, 27
BMO Capital ↗
Jul 9, 26
■ Market Perform neutral · not a buy · 🎯$95
Price at call : $91.34 — gap to target +4%
Today : $92.08 — gap to target +3%
🎯 on ZBH : no call matured yet · 📊 on Health : 60.4% · +8.8% (240 calls)
in progress (365j)
matures : Jul 9, 27
matures : Jul 9, 27
Evercore ISI Group ↗
Jul 6, 26
▲ Outperform · 🎯$110
Price at call : $89.41 — upside +23%
Today : $92.08 — upside +19%
🎯 on ZBH : no call matured yet · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Jul 6, 27
matures : Jul 6, 27
See the other 42 calls, newest to oldest
■ Neutral neutral · not a buy · 🎯$93
Price at call : $82.33 — gap to target +13%
Today : $92.08 — gap to target +1%
🎯 on ZBH : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : May 28, 27
matures : May 28, 27
■ Neutral neutral · not a buy · 🎯$95
Price at call : $82.43 — gap to target +15%
Today : $92.08 — gap to target +3%
🎯 on ZBH : no call matured yet · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Apr 29, 27
matures : Apr 29, 27
■ Neutral neutral · not a buy · 🎯$95
Price at call : $82.43 — gap to target +15%
Today : $92.08 — gap to target +3%
🎯 on ZBH : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Apr 29, 27
matures : Apr 29, 27
Citizens
Apr 29, 26
▲ Market Outperform · 🎯$105
Price at call : $82.43 — upside +27%
Today : $92.08 — upside +14%
🎯 on ZBH : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Apr 29, 27
matures : Apr 29, 27
Wells Fargo ↗
Apr 29, 26
■ Equal-Weight neutral · not a buy · 🎯$90
Price at call : $82.43 — gap to target +9%
Today : $92.08 — gap to target -2%
🎯 on ZBH : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Apr 29, 27
matures : Apr 29, 27
▼ Underweight · 🎯$94
Price at call : $82.43 — upside +14%
Today : $92.08 — upside +2%
🎯 on ZBH : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Apr 29, 27
matures : Apr 29, 27
Truist Securities ↗
Apr 29, 26
■ Hold neutral · not a buy · 🎯$92
Price at call : $82.43 — gap to target +12%
Today : $92.08 — gap to target -0%
🎯 on ZBH : no call matured yet · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Apr 29, 27
matures : Apr 29, 27
▲ Buy · 🎯$105
Price at call : $80.07 — upside +31%
Today : $92.08 — upside +14%
🎯 on ZBH : 0% (2 calls matureds) · 📊 on Health : 50.7% · +7.8% (304 calls)
in progress (365j)
matures : Apr 29, 27
matures : Apr 29, 27
Leerink Partners ↗
Apr 13, 26
■ Market Perform neutral · not a buy · 🎯$101
Price at call : $95.34 — gap to target +6%
Today : $92.08 — gap to target +10%
🎯 on ZBH : no call matured yet · 📊 on Health : 53.7% · -6.2% (41 calls)
in progress (365j)
matures : Apr 13, 27
matures : Apr 13, 27
■ Neutral neutral · not a buy
🎯 on ZBH : 0% (1 call matured) · 📊 on Health : 51.2% · +5.3% (123 calls)
in progress (365j)
matures : Mar 23, 27
matures : Mar 23, 27
▼ Underweight · 🎯$100
Price at call : $96.45 — upside +4%
Today : $92.08 — upside +9%
🎯 on ZBH : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Feb 12, 27
matures : Feb 12, 27
■ Neutral neutral · not a buy · 🎯$98
Price at call : $95.18 — gap to target +3%
Today : $92.08 — gap to target +6%
🎯 on ZBH : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Feb 11, 27
matures : Feb 11, 27
Wells Fargo ↗
Feb 11, 26
■ Equal-Weight neutral · not a buy · 🎯$98
Price at call : $95.18 — gap to target +3%
Today : $92.08 — gap to target +6%
🎯 on ZBH : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Feb 11, 27
matures : Feb 11, 27
▲ Buy · 🎯$112
Price at call : $95.61 — upside +17%
Today : $92.08 — upside +22%
🎯 on ZBH : 0% (1 call matured) · 📊 on Health : 51.2% · +5.3% (123 calls)
in progress (365j)
matures : Feb 10, 27
matures : Feb 10, 27
■ Hold neutral · not a buy
🎯 on ZBH : no call matured yet · 📊 on Health : 48.8% · +2.3% (160 calls)
in progress (365j)
matures : Feb 10, 27
matures : Feb 10, 27
▼ Sell · 🎯$86
Price at call : $86.02 — upside -0%
Today : $92.08 — upside -7%
🎯 on ZBH : 100% (1 call matured) · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Jan 28, 27
matures : Jan 28, 27
■ Market Perform neutral · not a buy · 🎯$99
Price at call : $91.45 — gap to target +8%
Today : $92.08 — gap to target +8%
🎯 on ZBH : no call matured yet · 📊 on Health : 55.7% · +5.7% (70 calls)
in progress (365j)
matures : Jan 9, 27
matures : Jan 9, 27
▲ Buy · 🎯$112
Price at call : $94.08 — upside +19%
Today : $92.08 — upside +22%
🎯 on ZBH : 0% (1 call matured) · 📊 on Health : 51.2% · +5.3% (123 calls)
in progress (365j)
matures : Jan 8, 27
matures : Jan 8, 27
Evercore ISI Group ↗
Jan 5, 26
▲ Outperform · 🎯$120
Price at call : $94.75 — upside +27%
Today : $92.08 — upside +30%
🎯 on ZBH : no call matured yet · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Jan 5, 27
matures : Jan 5, 27
■ Neutral neutral · not a buy · 🎯$100
Price at call : $90.91 — gap to target +10%
Today : $92.08 — gap to target +9%
🎯 on ZBH : no call matured yet · 📊 on Health : 51.3% · +6.1% (302 calls)
in progress (365j)
matures : Dec 16, 26
matures : Dec 16, 26
■ Neutral neutral · not a buy · 🎯$94
Price at call : $91.59 — gap to target +3%
Today : $92.08 — gap to target +2%
🎯 on ZBH : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Dec 11, 26
matures : Dec 11, 26
Canaccord Genuity ↗
Nov 10, 25
■ Hold neutral · not a buy · 🎯$93
Price at call : $88.5 — gap to target +5%
Today : $92.08 — gap to target +1%
🎯 on ZBH : no call matured yet · 📊 on Health : 52.6% · +5.0% (154 calls)
in progress (365j)
matures : Nov 10, 26
matures : Nov 10, 26
▼ Sell · 🎯$88
Price at call : $88.5 — upside -1%
Today : $92.08 — upside -4%
🎯 on ZBH : 100% (1 call matured) · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Nov 6, 26
matures : Nov 6, 26
RBC Capital ↗
Nov 6, 25
▲ Outperform · 🎯$101
Price at call : $88.5 — upside +14%
Today : $92.08 — upside +10%
🎯 on ZBH : 0% (1 call matured) · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Nov 6, 26
matures : Nov 6, 26
▼ Underweight · 🎯$104
Price at call : $88.5 — upside +18%
Today : $92.08 — upside +13%
🎯 on ZBH : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Nov 6, 26
matures : Nov 6, 26
■ Neutral neutral · not a buy · 🎯$100
Price at call : $88.51 — gap to target +13%
Today : $92.08 — gap to target +9%
🎯 on ZBH : no call matured yet · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Nov 6, 26
matures : Nov 6, 26
▼ Underweight · 🎯$105
Price at call : $88.51 — upside +19%
Today : $92.08 — upside +14%
🎯 on ZBH : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Nov 5, 26
matures : Nov 5, 26
▲ Buy · 🎯$112
Price at call : $88.51 — upside +27%
Today : $92.08 — upside +22%
🎯 on ZBH : 0% (1 call matured) · 📊 on Health : 51.2% · +5.3% (123 calls)
in progress (365j)
matures : Nov 5, 26
matures : Nov 5, 26
Canaccord Genuity ↗
Oct 22, 25
■ Hold neutral · not a buy · 🎯$101
Price at call : $103.16 — gap to target -2%
Today : $92.08 — gap to target +10%
🎯 on ZBH : no call matured yet · 📊 on Health : 52.6% · +5.0% (154 calls)
in progress (365j)
matures : Oct 22, 26
matures : Oct 22, 26
▲ Buy · 🎯$122
Price at call : $95.09 — upside +28%
Today : $92.08 — upside +32%
Expected +28% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on ZBH : 0% (1 call matured) · 📊 on Health : 51.2% · +5.3% (123 calls)
-3.2%
stock -3% · XLV +20%
matured Oct 13, 26
Evercore ISI Group ↗
Oct 7, 25
■ In-Line neutral · not a buy · 🎯$104
Price at call : $98.36 — gap to target +6%
Today : $92.08 — gap to target +13%
🎯 on ZBH : no call matured yet · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Oct 7, 26
matures : Oct 7, 26
▲ Buy · 🎯$118
Price at call : $101.74 — upside +16%
Today : $92.08 — upside +28%
Expected +16% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on ZBH : 0% (2 calls matureds) · 📊 on Health : 50.7% · +7.8% (304 calls)
-7.3%
stock -7% · XLV +24%
matured Sep 19, 26
Rothschild & Co
Sep 18, 25
▲ Buy · 🎯$130
Price at call : $100.09 — upside +30%
Today : $92.08 — upside +41%
Expected +30% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on ZBH : 0% (1 call matured) · 📊 unranked overall
-5.8%
stock -6% · XLV +23%
matured Sep 18, 26
RBC Capital ↗
Aug 8, 25
▲ Outperform · 🎯$115
Price at call : $100.02 — upside +15%
Today : $92.08 — upside +25%
Expected +15% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on ZBH : 0% (1 call matured) · 📊 on Health : 42.8% · -2.5% (397 calls)
-2.2%
stock -2% · XLV +29%
matured Aug 8, 26
▼ Sell · 🎯$96
Price at call : $100.02 — upside -4%
Today : $92.08 — upside +4%
Expected -4% · Actual -2% · Reason (≤ −15%) : ✗ No
🎯 on ZBH : 100% (1 call matured) · 📊 on Health : 51.7% · +3.1% (358 calls)
+2.2%
stock -2% · XLV +29%
matured Aug 8, 26
Raymond James ↗
Aug 8, 25
▲ Outperform · 🎯$113
Price at call : $100.02 — upside +13%
Today : $92.08 — upside +23%
Expected +13% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on ZBH : 0% (2 calls matureds) · 📊 on Health : 46.4% · +1.6% (403 calls)
-2.2%
stock -2% · XLV +29%
matured Aug 8, 26
Evercore ISI Group ↗
Jul 8, 25
■ In-Line neutral · not a buy · 🎯$96
Price at call : $93.47 — gap to target +3%
Today : $92.08 — gap to target +4%
🎯 on ZBH : no call matured yet · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Jul 8, 26
matures : Jul 8, 26
Canaccord Genuity ↗
May 12, 25
■ Hold neutral · not a buy · 🎯$101
Price at call : $98.22 — gap to target +3%
Today : $92.08 — gap to target +10%
🎯 on ZBH : no call matured yet · 📊 on Health : 52.6% · +5.0% (154 calls)
in progress (365j)
matures : May 12, 26
matures : May 12, 26
JMP Securities
May 7, 25
▲ Market Outperform · 🎯$125
Price at call : $95.11 — upside +31%
Today : $92.08 — upside +36%
Expected +31% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on ZBH : 0% (1 call matured) · 📊 unranked overall
-13.4%
stock -13% · XLV +7%
matured May 7, 26
Goldman Sachs ↗
May 6, 25
■ Neutral neutral · not a buy · 🎯$104
Price at call : $94.13 — gap to target +10%
Today : $92.08 — gap to target +13%
🎯 on ZBH : no call matured yet · 📊 on Health : 51.4% · +2.3% (243 calls)
in progress (365j)
matures : May 6, 26
matures : May 6, 26
Raymond James ↗
May 6, 25
▲ Outperform · 🎯$104
Price at call : $94.13 — upside +10%
Today : $92.08 — upside +13%
Expected +10% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on ZBH : 0% (2 calls matureds) · 📊 on Health : 46.4% · +1.6% (403 calls)
-11.4%
stock -11% · XLV +7%
matured May 6, 26
Frequently asked questions
Should I buy Zimmer Biomet stock?
This isn't buy advice. For Zimmer Biomet, the analyst consensus is "Hold", with an average price target of $100 (+9% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Zimmer Biomet). We show the numbers — you decide.
Is it too late to buy Zimmer Biomet? How high can it go?
The most bullish analyst target on Zimmer Biomet is $110 (+19% above today's price); the average is $100. That's the upside they see. Check how reliable those analysts have actually been on Zimmer Biomet on our site before trusting it.
Is Zimmer Biomet still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 27 analysts have a real record on Zimmer Biomet, the best hitting 100% over 2 calls. Current consensus: "Hold". Make your call on data, not noise.
Should you invest in Zimmer Biomet? The case for and against
The arguments for and against, one by one, from the numbers: why invest in ZBH (and why hesitate).
What has Zimmer Biomet's past performance been?
Historical returns and a "how much if I had invested" calculator: ZBH performance & returns.
Does Zimmer Biomet pay a dividend?
Yield, consistency and growth history of the dividend: ZBH's dividend.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX